In-vitro validation of potential modulators of non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver injury, compromising the liver’s regenerative ability and promoting fibrosis. Despite its widespread impact, therapeutic options remain limited. The only FDA-approved drug for NASH, Rezdiffra, had limited efficacy in pat...

Full description

Saved in:
Bibliographic Details
Main Author: Tang, Daryl Woon Tat
Other Authors: Torsten Wuestefeld
Format: Final Year Project
Language:English
Published: Nanyang Technological University 2024
Subjects:
Online Access:https://hdl.handle.net/10356/181271
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English